X0206 3/A 2012-05-31 2013-05-31 0 0001425205 Lion Biotechnologies, Inc. GNBP 0001471149 Ayer Capital Management, LP 230 CALIFORNIA, SUITE 600 SAN FRANCISCO CA 94111 0 0 1 0 0001519942 Ayer Capital Partners, LLC 230 CALIFORNIA, SUITE 600 SAN FRANCISCO CA 94111 0 0 1 0 0001519940 ACM Capital Partners, LLC 230 CALIFORNIA, SUITE 600 SAN FRANCISCO CA 94111 0 0 1 0 0001413350 Venkatesan Jay 230 CALIFORNIA STREET SUITE 600 SAN FRANCISCO CA 94111 0 0 1 0 Common stock 312500 I See Footnote Warrant (contains 4.9% blocker) 1.25 2011-07-26 2016-07-26 Common stock 2400000 I See Footnote Warrant (contains 4.9% blocker) 1.25 2012-02-20 2017-02-20 Common stock 960000 I See Footnote Convertible Note (contains 4.9%) 1.25 2011-07-26 2012-11-30 Common stock 3000000 I See Footnote Corporate Loan 1.25 2012-05-03 2012-06-30 Common Stock 1100000 I See Footnote These securities are held by investment funds and a managed account, the investment advisor of which is Ayer Capital Management, LP (the "Advisor"), ACM Capital Partners, LLC ("ACM")is the General Partner of the Advisor, Ayer Capital Partners, LLC (the "GP") is the General Partner of the investment funds. Mr. Venkatesan is the managing member of ACM and the General Partner of the GP. Each of the Advisor, ACM, the GP, and Mr. Venkatesan disclaims beneficial ownership of these securities except to the extent of its or his pecuniary interest thereof, and the filing of this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Each of the derivative securities listed above cannot be exercised or converted into more than 4.9% of the outstanding shares of the issuer's common stock, pursuant to written agreement with issuer. On behalf of Ayer Capital Management, LP, Jay Venkatesan, 2012-05-31 On behalf of Ayer Capital Partners, LLC, Jay Venkatesan, General Partner 2012-05-31 On behalf of ACM Capital Partners LLC, Jay Venkatesan, Managing Member 2012-05-31 Jay Venkatesan 2012-05-31